TreeFrog Therapeutics announces grounbreaking collaboration with GAIA BioMedicine

Eic scaling up company TreeFrog Therapeutics* announced last week a collaboration with clinical-stage Japanese #biotech *GAIA BioMedicine for the expansion of allogeneic NK-like #cells against solid tumors.

 

“It’s the first time that TreeFrog announces a collaboration with a clinical-stage partner. This is a unique opportunity to brig rapidly the benefits of our technology- C-Stem- to patients,” TreeFrog Therapeutics CEO Frédéric Desdouits said. “The main objective of this partnership is to use C-Stem technology to mass-amplify those NK cells while preserving their phenotype.”



* TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. 

*In the field of cell therapy for cancer, GAIA BioMedecine is one of the most advanced players with NK cells, with 3 on-going clinical trials in solid tumors: lung, pancreatic gastric cancer, and also neuroblastoma. 

 

#healthtech #medtech #celltherapies #scaleup #EUeic